Characteristics of dialysis-related amyloidosis in patients on haemodialysis therapy for more than 30 years

Background. Dialysis-related amyloidosis is one of the chronic the complications of haemodialysis. We conducted an investigation of dialysis-associated amyloidosis in extremely long-term survivors. Methods. Twenty-one patients on haemodialysis for more than 30 years (‘30+’ group) and 13 patients on...

Full description

Saved in:
Bibliographic Details
Published inNephrology, dialysis, transplantation Vol. 24; no. 5; pp. 1593 - 1598
Main Authors Otsubo, Shigeru, Kimata, Naoki, Okutsu, Ichiro, Oshikawa, Kazunori, Ueda, Syuitsu, Sugimoto, Hisayuki, Mitobe, Michihiro, Uchida, Keiko, Otsubo, Kimiko, Nitta, Kosaku, Akiba, Takashi
Format Journal Article
LanguageEnglish
Published Oxford Oxford University Press 01.05.2009
Oxford Publishing Limited (England)
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background. Dialysis-related amyloidosis is one of the chronic the complications of haemodialysis. We conducted an investigation of dialysis-associated amyloidosis in extremely long-term survivors. Methods. Twenty-one patients on haemodialysis for more than 30 years (‘30+’ group) and 13 patients on haemodialysis for 20–30 years (‘20–30’ group) at Sangenjaya Hospital were enrolled in this study. The frequencies of operations for conditions related to haemodialysis-related amyloidosis were examined. Results. The mean age at the start of haemodialysis was younger in the ‘30+’ group (29.1 ± 7.3 years) than in the ‘20–30’ group (40.5 ± 8.2 years, P = 0.0003). Eighteen (85.7%) patients had undergone surgery for CTS, six (28.6%) had undergone surgery for trigger finger and six (28.6%) had undergone surgery for cervical destructive spondyloarthropathy (DSA) at 30 years after the start of haemodialysis therapy. Patients who were over the age of 30 years at the start of dialysis therapy more frequently underwent CTS operations (100%) than those who were under 30 years of age at the start of dialysis (76.9%; P = 0.025) in the ‘30+’ group at 30 years after the start of haemodialysis. The frequencies of operations for CTS did not differ significantly between the ‘20–30’ group and the ‘30+’ group. Conclusions.Haemodialysis-associated amyloidosis was common in extremely long-term survivors. Even though the mean age at the start of haemodialysis was younger in the ‘30+’ group than in the ‘20–30’ group, the frequency of operations for CTS did not differ. This may be attributable to the recent advances in haemodialysis technologies.
Bibliography:istex:E65DC21D3F2D8E566E6497A4A9A76D5FFF4D7942
ArticleID:gfn706
ark:/67375/HXZ-RF7T9ZWQ-G
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0931-0509
1460-2385
DOI:10.1093/ndt/gfn706